ZNF665
Zinc finger protein 665
Also known as: FLJ14345, ZFP160L, ZN665_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H7R5
- Gene
- ZNF665
- Ensembl
- ENSG00000197497
- Chromosome
- 19
- Canonical length
- 678 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nuclear membrane
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
678 residues, UniProt reviewed canonical sequence.
>Q9H7R5|ZNF665
1 MALPQGQLTF KDVAIEFSQE EWTCLDPAQK TLYRDVMLEN YRNLVSLDIS CKCVNTDLPP
61 KGKNNMGEAF YTVKLERLES CDTVGLSFQE VQKNTYDFEC QWKDDEGNYK TVLMLQKENL
121 PGRRAQRDRR AAGNRHIENQ LGVSFQSHLP ELQQFQHEGK IYEYNQVEKS PNNRGKHYKC
181 DECGKVFSQN SRLTSHKRIH TGEKPYQCNK CGKAFTVRSN LTIHQVIHTG EKPYKCNECG
241 KVFSQPSNLA GHQRIHTGEK PYKCNECGKA FRAHSKLTTH QVIHTGEKPY KCKECGKCFT
301 QNSHLASHRR IHTGEKPYKC NECGKAFSVR SSLTTHQTIH TGEKPYKCNE CGKVFRHNSY
361 LAKHRRIHTG EKPYKCNECG KAFSMHSNLT KHQIIHTGEK PFKCNECVKV FTQYSHLANH
421 RRIHTGEKPY RCDECGKAFS VRSSLTTHQA IHTGEKPYKC NDCGKVFTQN SHLASHRGIH
481 SGEKPYKCDE CGKAFSQTSQ LARHWRVHTG EKPYKCNECG KAFSVHSSLT IHQTIHTGQK
541 PYKCNDCGKV FRHNSYLAIH QRIHTGEKPY KCNECGKAFS VHSNLATHQV IHTGEKPYKC
601 NECGKVFTQN SHLANHRRIH TGEKPYRCNE CGKAFSVRST LTTHMAVHTG DKPYKCNQCG
661 KVFTQNSNLA KHRRIHSGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF665 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 2.3 nTPM
Expression across tissuesHPA
Tissue
- ovary: 2.3 nTPM
- fallopian tube: 1.7 nTPM
- parathyroid gland: 1.4 nTPM
- thymus: 1.4 nTPM
- thyroid gland: 1.4 nTPM
- breast: 1.2 nTPM
Single-cell type
- ovarian stromal cells: 17 nCPM
- fibro-adipogenic progenitors: 16 nCPM
- differentiating spermatogonia: 13 nCPM
- bergmann glia: 12 nCPM
- myosatellite cells: 12 nCPM
- basal prostatic cells: 11 nCPM
Immune cell
- naive B-cell: 2.1 nTPM
- NK-cell: 2 nTPM
- memory B-cell: 1.2 nTPM
- memory CD8 T-cell: 0.9 nTPM
- naive CD8 T-cell: 0.8 nTPM
- naive CD4 T-cell: 0.7 nTPM
Brain region
- cerebellum: 7.2 nTPM
- white matter: 6.3 nTPM
- cerebral cortex: 4.8 nTPM
- midbrain: 4.8 nTPM
- basal ganglia: 4.7 nTPM
- medulla oblongata: 4.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.8
- gnomAD pLI
- 0.01
- gnomAD missense Z
- -0.76
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF665 as an antibody target. Whether an autoantibody or antibody against ZNF665 could matter depends on whether native ZNF665 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF665 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF665 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...